lesson 5 - viral vectors #1

Detailed Explanation of Gene and Cell Therapy Content

Gene Therapy: This is a medical technique that involves altering the genes inside a patient's cells to treat or prevent disease. Often it utilizes modified DNA to either replace or repair abnormal genes that are responsible for disease development.
Viral Vectors: These are specially modified viruses that deliver therapeutic genes into cells. An example provided is the adenovirus, which serves as a vector to carry the modified genetic material into target cells.
Steps: The process involves injecting modified viral DNA into an adenovirus vector, which then attaches to the cell membrane, leading to the entry of the vector into the cell. Inside, it releases the new gene into the cell nucleus where protein synthesis occurs.

Challenges Identified (1972- Present): This section discusses the ongoing challenges faced in the field of gene therapy, including:
- Exogenous DNA Integration: The difficulty of integrating new DNA into the host chromosome effectively.
- Expression of New Genes: Ensuring that the new genes function properly once transferred.
- Stability of Applications: Maintaining the effectiveness and stability of gene therapy outcomes.
- Viral DNA: Highlights the importance of viral DNA in achieving successful gene therapy.

Direct Delivery: This refers to the method where therapeutic transgenes are introduced directly to target organs—like the liver—through viral vectors.
Cell-Based Delivery: In this method, stem cells are harvested from the patient, modified with the therapeutic transgene, multiplied, and then reintroduced into the patient’s body.

Ex-vivo Gene Therapy:
- Advantages: Allows for controlled manipulation of specific cell populations and accurate dosing.
- Limitations: There are risks that target cells may not survive the manipulation and may face challenges in reintegration.
In-vivo Gene Therapy:
- Advantages: Can target multiple tissues, broadening the potential applications.
- Limitations: Effectiveness is limited to systems that allow efficient viral transmission and potential immune response risks against the vectors.

Types of Viral Vectors:
- Gamma Retrovirus: Targets primarily dividing cells.
- Lentivirus (LV): Able to transduce both dividing and non-dividing cells.
- Adenovirus (AdV): Noted for its high transduction efficiency and wide tropism.
- Adeno-associated Virus (AAV): Non-pathogenic and has a smaller payload capacity.
Mechanisms of Infection: Discusses how these vectors infect cells, involving steps such as membrane fusion and endosomal escape.

Clinical Trials Landscape (2008-2018): Provides an overview of viral vector usage in clinical trials, noting that adenovirus remains the most frequently used vector alongside plasmid DNA and retrovirus, including trends in efficacy and safety.

2020 Clinical Trials: Analyzes the distribution of gene transfer vectors in Advanced Therapy Medicinal Product (ATMP) trials, indicating that adenovirus and lentivirus were most common.

Definition of a Virus: A virus is described as a small parasite that must infect a host cell to reproduce, emphasizing its reliance on host cellular machinery for replication.

Provides a concise overview of viral replication within a host cell, detailing the stages from entry of the virus to the release of new viral particles.

Nucleic Acid Types: Discusses RNA and DNA viruses, differentiating them based on their structural characteristics and symmetry.
Viral Families Classification: Classifies viruses according to genome structure and replication methods.

Reviews the various classes of DNA and RNA viruses, highlighting structural differences and distinct replication strategies.

This section contrasts somatic expression with genome integration facilitated by viral vectors, detailing mechanisms such as endocytosis and transcription into mRNA.

Presents key characteristics of commonly used viral vectors in gene therapy, accompanied by diagrams to illustrate their genetic structures and capacities.

Outlines the main groups of viral vectors including retrovirus, lentivirus, AAV, and adenovirus. Discusses pros such as high efficiency and broad targeting contrasted with cons like safety issues and capacity limitations for gene insertion.

Evaluates the advantages of retrovirus vectors regarding transduction rates while also acknowledging risks such as insertional mutagenesis.

Regulatory Framework: Discusses the overview of regulatory bodies such as the FDA in the U.S. and EMA in Europe, which oversee gene therapy trials and approval processes. The importance of protocols for safety and efficacy evaluations before clinical application is emphasized.
Ethical Considerations: This section addresses the ethical implications of gene therapy, including concerns about genetic modifications, consent for experimental treatments, and potential long-term effects on patients and future generations.

Advancements in Gene Editing: Highlights recent technologies like CRISPR-Cas9 that have revolutionized gene therapy by allowing precise modifications of genomic DNA.
Gene Therapy Clinical Applications: Outlines current diseases being targeted by gene therapy, including inherited disorders, certain types of cancer, and viral infections, showcasing ongoing clinical trials and research.
Future Directions: Speculates on the future of gene therapy, including personalized medicine approaches and the integration of gene therapy with other biotechnologies such as regenerative medicine.

Successful Gene Therapy Cases: Reviews notable case studies where gene therapy has shown significant positive outcomes, such as patients with inherited blindness or severe combined immunodeficiency (SCID), detailing the methodologies and results.
Limitations and Failures: This section discusses instances where gene therapy has not met expectations, analyzing the reasons behind the setbacks encountered in clinical applications.

Summary of Key Points: Recaps the critical aspects of gene therapy including its mechanisms, challenges, and ongoing advancements.
The Future of Gene and Cell Therapy: Ends with a hopeful outlook on the continued evolution of gene therapy techniques and their potential to transform medicine and treat previously untreatable conditions.